TY - JOUR
T1 - Fluorescent Detection of O-GlcNAc via Tandem Glycan Labeling
AU - Wu, Zhengliang L.
AU - Luo, Ang
AU - Grill, Alex
AU - Lao, Taotao
AU - Zou, Yonglong
AU - Chen, Yue
N1 - Publisher Copyright:
Copyright © 2020 American Chemical Society.
PY - 2020/9/16
Y1 - 2020/9/16
N2 - O-GlcNAcylation is a reversible serine/threonine glycosylation on cytosolic and nuclear proteins that are involved in various regulatory pathways. However, the detection and quantification of O-GlcNAcylation substrates have been challenging. Here, we report a highly efficient method for the identification of O-GlcNAc modification via tandem glycan labeling, in which O-GlcNAc is first galactosylated and then sialylated with a fluorophore-conjugated sialic acid residue, therefore enabling highly sensitive fluorescent detection. The method is validated on various proteins that are known to be modified by O-GlcNAcylation including CK2, NOD2, SREBP1c, AKT1, PKM, and PFKFB3, and on the nuclear extract of HEK293 cells. Using this method, we then report the evidence that hypoxia-inducible factor HIF1α is a potential target for O-GlcNAcylation, suggesting a possibly direct connection between the metabolic O-GlcNAc pathway and the hypoxia pathway.
AB - O-GlcNAcylation is a reversible serine/threonine glycosylation on cytosolic and nuclear proteins that are involved in various regulatory pathways. However, the detection and quantification of O-GlcNAcylation substrates have been challenging. Here, we report a highly efficient method for the identification of O-GlcNAc modification via tandem glycan labeling, in which O-GlcNAc is first galactosylated and then sialylated with a fluorophore-conjugated sialic acid residue, therefore enabling highly sensitive fluorescent detection. The method is validated on various proteins that are known to be modified by O-GlcNAcylation including CK2, NOD2, SREBP1c, AKT1, PKM, and PFKFB3, and on the nuclear extract of HEK293 cells. Using this method, we then report the evidence that hypoxia-inducible factor HIF1α is a potential target for O-GlcNAcylation, suggesting a possibly direct connection between the metabolic O-GlcNAc pathway and the hypoxia pathway.
UR - https://www.scopus.com/pages/publications/85091126940
UR - https://www.scopus.com/inward/citedby.url?scp=85091126940&partnerID=8YFLogxK
U2 - 10.1021/acs.bioconjchem.0c00454
DO - 10.1021/acs.bioconjchem.0c00454
M3 - Article
C2 - 32830957
AN - SCOPUS:85091126940
SN - 1043-1802
VL - 31
SP - 2098
EP - 2102
JO - Bioconjugate Chemistry
JF - Bioconjugate Chemistry
IS - 9
ER -